恐竜の謎 : 地球の電磁場により、恐竜の巨大化と絶滅を説明できる可能性がある
スポンサーリンク
概要
- 論文の詳細を見る
Why dinosaurs became so large and why they became extinct are two of the great mysteries of biology. However, no theory has yet succeeded in explaining the biotic transitions adequately. In a previous meta-analysis, we found that exposure to an extremely low frequency electromagnetic field (ELF-EMF) was associated with an increase in animal body weight. In the present paper, we propose that the large body size of the dinosaurs was caused by ELF-EMFs generated by natural phenomena: geomagnetic storms, volcanic activity, earthquakes, or Schumann resonance. To support this hypothesis, we researched long-term data on changes in these processes. We found that there was a high level of crustal change during the age of the dinosaurs. We propose that Ultra-low frequency (ULF)/ELF-EMFs produced by widespread earthquakes and volcanism caused the dinosaurs to become larger, then when these phenomena were no longer so prevalent, the dinosaurs became extinct for a number of reasons, among them the loss of ULF/ELF-EMFs.
- 2010-03-01
著者
-
FUKUSHIMA Masanori
Translational Research Center, Kyoto University Hospital, Kyoto University Graduate School of Medici
-
西村 勉
Translational Research Center, Graduate School of Medicine, Kyoto University
-
Mohri Kaneo
Aichi Micro Intelligent Corporation
-
西村 勉
Translational Research Center Graduate School Of Medicine Kyoto University
-
Mohri Kaneo
Aichi Micro Intelligent Corporation:nagoya Industrial Sciences Research Institute
-
Fukushima Masanori
Translational Research Center Graduate School Of Medicine Kyoto University
関連論文
- 恐竜の謎 : 地球の電磁場により、恐竜の巨大化と絶滅を説明できる可能性がある
- Long-Term Probucol Treatment Prevents Secondary Cardiovascular Events : a Cohort Study of Patients with Heterozygous Familial Hypercholesterolemia in Japan
- P11-6 ゲフィチニブ(イレッサ_[R!○])による有害事象の発現および効果に関するレトロスペクティブ調査(JMTO LC03-02)(ポスター総括11 : 基礎 ゲフィチニブ(臨床))
- 地球の磁場や電磁場により、BERGMANNの法則、COPEの法則、RENSCHの法則を説明することができる
- Coronary Risk Factor Profile and Prognostic Factors for Young Japanese Patients Undergoing Coronary Revascularization
- 2 Prognosis of Japanese Patients after Coronary Revascularization : Perspectives from CREDO-Kyoto Registry(Therapeutic Decision Making for Coronary Artery Disease Among PCI, CABG, and Medication,Symposium 3 (SY-03) (IHD),The 73rd Annual Scientific Meeting
- 3 Prevalence and Significance of Risk Factors in Japanese Patients Undergoing Coronary Revascularization : from CREDO-Kyoto Registry(Comprehensive Risk Management for Prevention of Coronary Artery Disease,Symposium 16 (SY-16) (H),The 73rd Annual Scientifi
- Candesartan Antihypertensive Survival Evaluation in Japan (CASE-J) Trial of Cardiovascular Events in High-Risk Hypertensive Patients : Rationale, Design, and Methods
- UGT1A1^*6 polymorphism is most predictive of severe neutropenia induced by irinotecan in Japanese cancer patients
- Prevalence and Incidence of Anemia in Japanese Cancer Patients Receiving Outpatient Chemotherapy
- Better Survival With Statin Administration After Revascularization Therapy in Japanese Patients With Coronary Artery Disease : Perspectives From the CREDO-Kyoto Registry
- OE-007 Impact of Statins on the Outcome of Patients after Coronary Revascularization in the Real World Clinical Practice : CREDO-Kyoto Study(Coronary revascularization, PCI(01)(IHD),Oral Presentation(English),The 72nd Annual Scientific Meeting of the Japa
- THE MYSTERY OF THE DINOSAURS : THE EARTH'S ELECTROMAGNETIC FIELD MAY EXPLAIN THEIR GIANTISM AND EXTINCTION
- PE-470 Anemia Predicts 3-Years Mortality and Cardiovascular Events in Patients Undergoing Elective Revascularization : from the CREDO-Kyoto(Chronic coronary heart disease/Remodeling-3, The 71st Annual Scientific Meeting of the Japanese Circulation Society
- FRS-086 Comparison of Survival After Coronary Revascularization of Diabetic Patients Receiving Insulin Versus Those Receiving only Diet and/or Oral Hypoglycemic Agents.(New Insights into Metabolic Syndrome(01)(H),Featured Research Session,The 72nd Annual
- PJ-353 Comparison of Percutaneous Coronary Intervention (PCI) and Coronary Artery Bypass Graft Surgery (CABG) in Patients with Multi-vessel Disease (MVD)(Coronary revascularization, PCI-15 (IHD) PJ60,Poster Session (Japanese),The 70th Anniversary Annual S
- Surrogacy of tumor response and progression-free survival for overall survival in metastatic breast cancer resistant to both anthracyclines and taxanes
- Phase II Clinical Trial of CD34+ Cell Therapy to Explore Endpoint Selection and Timing in Patients With Critical Limb Ischemia